0001140361-21-021495.txt : 20210617 0001140361-21-021495.hdr.sgml : 20210617 20210617190349 ACCESSION NUMBER: 0001140361-21-021495 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210617 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SYKES RICHARD CENTRAL INDEX KEY: 0001372810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 211026458 MAIL ADDRESS: STREET 1: C/O PDS BIOTECHNOLOGY CORPORATION STREET 2: 25B VREELAND ROAD CITY: FLORHAM PARK STATE: NJ ZIP: 07932 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 4 1 form4.xml FORM 4 X0306 4 2021-06-17 0001472091 PDS Biotechnology Corp PDSB 0001372810 SYKES RICHARD C/O PDS BIOTECHNOLOGY CORPORATION 25B VREELAND ROAD FLORHAM PARK NJ 07932 true Stock Option (Right to Buy) 9.95 2021-06-17 4 A 0 9000 0 A 2031-06-17 Common Stock 9000 9000 D The Stock Option will vest in full and become fully exercisable on June 17, 2022. /s/ Hillary Yegen, attorney-in-fact 2021-06-17